Elevated serum levels of osteopontin in HCV-associated lymphoproliferative disorders
Massimo Libra(University of Catania), María Clorinda Mazzarino(University of Catania), Anna Linda Zignego(University of Florence), Umberto Dianzani(University of Turin), James A. McCubrey(East Carolina University), Vallì De Re(Centro di Riferimento Oncologico), Grazia Malaponte(University of Catania), Manuela Indelicato(University of Catania), F Stivala(University of Catania), Annalisa Chiocchetti(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Ferdinando Nicoletti(University of Catania)
Cited by 27
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
|Frontiers in Pharmacology|2018|878
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508